Altus Drug Development is a specialist CDMO using our range of differentiating technologies and our vast experience of NCE, NME and Value-Added Medicine development to provide patent-protected new products for our partners. Altus Drug Development offers a range of services to move your drug from Lab to Clinic to Market swiftly and cost-effectively.
The Altus Advantage
Altus Patent Umbrella
Lab to Clinic to Market
Integrated Drug Development Services
Preclinical Testing and Lead Selection
First in Human (FIH) Studies
Launch & Commercial Supplies
The Advantages of Value-Added Medicines
Altus Value-Added Medicines bring commercially and clinically meaningful benefits to new molecules (NCE or NME) and old, generating new labelling to avoid substitution while addressing the needs of patients, healthcare professionals and payers. Altus Value-Added Medicines allow premium pricing.
Let Us Help You